NASDAQ · CMPX
Compass Therapeutics, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CMPX: Nov 4, 2026
Compass Therapeutics, Inc. Common Stock is estimated to report earnings on 11/04/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 6 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.12. The reported EPS for the same quarter last year was $-0.08.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.12 | $-0.10 | $-0.15 | 6 |
| Dec 2026 | $-0.13 | $-0.10 | $-0.17 | 6 |
| Mar 2027 | $-0.12 | $-0.10 | $-0.13 | 4 |
| Jun 2027 | $-0.13 | $-0.10 | $-0.14 | 4 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
BNK Invest · MarketBeat · RTTNews · The Motley Fool- BNK Invest · Aug 18, 5:33 PM EDTNotable Tuesday Option Activity: PLNT, BE, CMPXAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Planet Fitness Inc (Symbol: PLNT), where a total of 16,974 contracts have traded so far, representing approximately 1.7 million underlying shares. That amounts to about
- MarketBeat · Jun 8, 9:06 AM EDTCompass Therapeutics Eyes FDA Path After Tovecimig Trial WinTop 3 High-Momentum Companies Analysts Are Still Bullish OnCompass Therapeutics (NASDAQ:CMPX) Chief Executive Officer Tom Schuetz said the company is preparing for a key U.S. Food and Drug Administration meeting on tovecimig, its DLL4/VEGF bispecific antibody, after a randomized
- RTTNews · May 26, 3:38 AM EDTCompass Therapeutics To Present Phase 1 Data Results Of CTX-8371 At ASCO 2026(RTTNews) – Compass Therapeutics, Inc. (CMPX), a clinical-stage, oncology-focused biopharmaceutical company, reported a poster presentation of promising Phase 1 results of CTX-8371 in patients with advanced malignancies treated in post-checkpoint inhibitor setting. The results wi
- RTTNews · Apr 30, 9:47 AM EDTWeekly Buzz: FDA Okays Saphnelo Pen, EC Clears Acromegaly Drug, SNGX Slumps, LGND Snaps Up XOMA(RTTNews) – This week's biotech landscape witnessed regulatory approvals in the US and Europe, acquisitions, and a few trial halts, alongside positive data readouts spanning multiple therapeutic areas, including Type 1 Diabetes, Male Pattern Hair Loss, and Hereditary angioedema.
- BNK Invest · Apr 27, 3:34 PM EDTNoteworthy Monday Option Activity: CLF, CMPX, CVILooking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cleveland-Cliffs Inc (Symbol: CLF), where a total volume of 110,580 contracts has been traded thus far today, a contract volume which is representative of approx
- RTTNews · Apr 27, 9:48 AM EDTCMPX Slumps As Tovecimig Misses Overall Survival Secondary Endpoint In Biliary Tract Cancer Trial(RTTNews) – Shares of Compass Therapeutics Inc. (CMPX) are down more than 63% in pre-market trading despite the company reporting that its investigational antibody Tovecimig achieved a highly statistically significant improvement in progression-free survival in the COMPANION-002
- RTTNews · Apr 27, 1:52 AM EDTCompass To Unveil Phase 2/3 COMPANION-002 Topline Data For Tovecimig In BTC; Stock Up(RTTNews) – Compass Therapeutics, Inc. (CMPX), a clinical-stage biopharmaceutical company, will review topline secondary endpoints from its Phase 2/3 COMPANION-002 clinical study assessing the Tovecimig combination with Paclitaxel in patients with advanced biliary tract cancer (B
- BNK Invest · Apr 16, 3:20 PM EDTNoteworthy Thursday Option Activity: CAR, RKLB, CMPXAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Avis Budget Group Inc (Symbol: CAR), where a total of 38,605 contracts have traded so far, representing approximately 3.9 million underlying shares. That amounts to abou
- BNK Invest · Mar 31, 3:19 PM EDTNotable Tuesday Option Activity: BA, GOOG, CMPXAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Boeing Co. (Symbol: BA), where a total of 63,566 contracts have traded so far, representing approximately 6.4 million underlying shares. That amounts to about 83% of BA'
- The Motley Fool · Mar 2, 12:49 PM ESTInvestment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC FilingPurchased 2,532,419 shares in CMPX; position value was $13,599,090 as of December 31, 2025
- BNK Invest · Feb 27, 10:37 AM ESTFirst Week of CMPX January 2027 Options TradingInvestors in Compass Therapeutics Inc (Symbol: CMPX) saw new options become available this week, for the January 2027 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 322 days until expiration the newly ava
- Zacks · Feb 17, 9:40 AM ESTIs Compass Therapeutics, Inc. (CMPX) Outperforming Other Medical Stocks This Year?Here is how Compass Therapeutics, Inc. (CMPX) and Ekso Bionics (EKSO) have performed compared to their sector so far this year.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Compass Therapeutics, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.